Planet First Partners has invested in Iterative Health, following the company’s $77 million Series C funding round, to support its mission of accelerating clinical research through AI-enabled technology and clinical trial infrastructure. The company addresses one of the biggest challenges in clinical research—slow patient enrollment and delayed trial execution—by embedding research directly into routine clinical care. Its integrated platform combines centralized operations, expert staffing, proprietary AI, and clinical trial expertise, achieving twice the site activation speed and three times higher patient enrollment than industry benchmarks.
Iterative Health’s research network now spans more than 100 sites across North America, Europe, India, and Australia, working with over 40 pharmaceutical, biotechnology, and CRO partners. The new funding will support expansion beyond gastroenterology and hepatology into cardiology and obesity, while continuing geographic growth.